Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Egarter

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Hormone Molecular Biology and Clinical Investigation|January 11, 2020
Progestogen-only pills: which progestogen would be idealChristian Egarter
Menopause (New York, N.Y.)|June 7, 2003
Effects of tibolone on cell adhesion molecules in postmenopausal womenChristian Egarter, Michael Sator, Johannes Huber
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|December 20, 2021
Dydrogesterone after 60 years: a glance at the safety profileJohannes Ott, Christian Egarter, Alex Aguilera
Menopause (New York, N.Y.)|January 25, 2003
Tibolone was associated with an increase in 7 alpha-methyl-ethinylestradiolChristian Egarter, Herbert Kuhl, Inka Wiegratz
Acta Obstetricia Et Gynecologica Scandinavica|August 23, 2002
Hormone replacement therapy with tibolone: effects on sexual functioning in postmenopausal womenChristian Egarter, AtaM Topcuoglu, Sonja Vogl, et al.
The Journal of Reproductive Medicine|March 9, 2002
A randomized trial of vaginal prostaglandin E2 for induction of labor. Insert vs. tabletMichaela Rabl, Elmar A Joura, Yüksel Yücel, et al.
Archives of Gynecology and Obstetrics|May 19, 2019
The impact of a standardized micronutrient supplementation on PCOS-typical parameters: a randomized controlled trialMarlene Hager, Kazem Nouri, Martin Imhof, et al.
Contraception|June 18, 2013
Removal of non-palpable Implanon® with the aid of a hook-wire markerKazem Nouri, Katia Pinker-Domenig, Johannes Ott, et al.
Disease Markers|February 19, 2010
A polymorphism of the corticotropin-releasing hormone receptor 2 (CRHR2) and preterm birthMaximilian Schmid, Christoph Grimm, Heinz Leipold, et al.
Wiener Klinische Wochenschrift|March 15, 2003
Redistribution of corticotropin-releasing hormone receptor R2 using fluorescence immunohistochemistry in fetal membranes of women delivering preterm or at termStefan Jirecek, Barbara Tringler, Martin Knöfler, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Hormone Molecular Biology and Clinical Investigation|January 11, 2020
Progestogen-only pills: which progestogen would be idealChristian Egarter
Menopause (New York, N.Y.)|June 7, 2003
Effects of tibolone on cell adhesion molecules in postmenopausal womenChristian Egarter, Michael Sator, Johannes Huber
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|December 20, 2021
Dydrogesterone after 60 years: a glance at the safety profileJohannes Ott, Christian Egarter, Alex Aguilera
Menopause (New York, N.Y.)|January 25, 2003
Tibolone was associated with an increase in 7 alpha-methyl-ethinylestradiolChristian Egarter, Herbert Kuhl, Inka Wiegratz
Acta Obstetricia Et Gynecologica Scandinavica|August 23, 2002
Hormone replacement therapy with tibolone: effects on sexual functioning in postmenopausal womenChristian Egarter, AtaM Topcuoglu, Sonja Vogl, et al.
The Journal of Reproductive Medicine|March 9, 2002
A randomized trial of vaginal prostaglandin E2 for induction of labor. Insert vs. tabletMichaela Rabl, Elmar A Joura, Yüksel Yücel, et al.
Archives of Gynecology and Obstetrics|May 19, 2019
The impact of a standardized micronutrient supplementation on PCOS-typical parameters: a randomized controlled trialMarlene Hager, Kazem Nouri, Martin Imhof, et al.
Contraception|June 18, 2013
Removal of non-palpable Implanon® with the aid of a hook-wire markerKazem Nouri, Katia Pinker-Domenig, Johannes Ott, et al.
Disease Markers|February 19, 2010
A polymorphism of the corticotropin-releasing hormone receptor 2 (CRHR2) and preterm birthMaximilian Schmid, Christoph Grimm, Heinz Leipold, et al.
Wiener Klinische Wochenschrift|March 15, 2003
Redistribution of corticotropin-releasing hormone receptor R2 using fluorescence immunohistochemistry in fetal membranes of women delivering preterm or at termStefan Jirecek, Barbara Tringler, Martin Knöfler, et al.
Pageof 4